Artificial Intelligence (AI) - Based Chatb

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

HOME | SUBMIT | FAQ | BLOG | ALERTS / RSS | RESOURCES

| ABOUT

Search 
Advanced Search

 Follow this preprint

Artificial Intelligence (AI)-based


Chatbots in Promoting Health
Behavioral Changes: A Systematic
Review

 Abhishek Aggarwal, Cheuk Chi Tam, Dezhi Wu,


Xiaoming Li, Shan Qiao
doi: https://doi.org/10.1101/2022.07.05.22277263
Now published in Journal of Medical Internet Research doi:
10.2196/40789

0 0 0 0 3 0 2

Abstract Full Text

Info/History Metrics

 Preview PDF

Abstract

Background Artificial-Intelligence (AI)-based chatbots


can offer personalized, engaging, and on-demand
health-promotion interventions. This systematic review
evaluates the feasibility, efficacy, and intervention
characteristics of AI-chatbots in promoting health-
behavior change.

Methods A comprehensive search was conducted in


seven bibliographic databases (PubMed, IEEE Xplore,
ACM Digital Library, PsychoINFO, Web of Science,
EMBASE, and JMIR publications) for empirical articles
published from 1980 to 2022 that evaluated feasibility
and/or efficacy of AI-chatbots for behavioral change.
The screening, extraction, and analyses of identified
articles followed the PRISMA guidelines.

Results Of the 15 included studies, majority studies


(n=11) reported high usability, acceptability and
engagement, and some evidence on feasibility of AI-
chatbots. Selected studies demonstrated high efficacy
in promoting healthy lifestyles (n=6), smoking
cessation (n=4), treatment/medication adherence
(n=2), and reduction in substance misuse (n=1).
Behavioral change theories and/or expert consultation
were used to develop behavioral change strategies of
AI-chatbots, including goal setting, monitoring, real-
time reinforcement/feedback, and on- demand
support. Real-time user-chatbot interaction data, such
as user preferences and behavioral performance,
were collected on the chatbot platform to identify ways
of providing personalized services. The AI-chatbots
demonstrated potential for scalability by deployment
through accessible devices and platforms (e.g.,
smartphones and messenger). Participants also
reported that AI-chatbots offered a non-judgmental
space for communicating sensitive information.
However, the reported results need to be interpreted
with caution because of moderate to high risk of
internal validity, insufficient description of AI-
techniques, and limitation for generalizability.

Conclusion AI-chatbots have demonstrated efficacy


of health-behavior change interventions among large
and diverse population; however, future studies need
to adopt robust RCTs to establish definitive
conclusions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Research reported in this publication was supported


by the National Institutes of Allergy and Infectious
Disease under Award #R01AI127203-5S1. The
content is solely the responsibility of the authors and
does not necessarily represent the official views of the
National Institutes of Health. The authors would also
like to acknowledge the generous funding support
from the University of South Carolina (USC) Big Data
Health Science Center, a USC excellence initiative
program [Grant No: BDHSC-2021-14] and [Grant No:
BDHSC-2021-11].

Author Declarations

I confirm all relevant ethical guidelines have been


followed, and any necessary IRB and/or ethics
committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent


has been obtained and the appropriate institutional
forms have been archived, and that any
patient/participant/sample identifiers included were not
known to anyone (e.g., hospital staff, patients or
participants themselves) outside the research group
so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other


prospective interventional studies must be registered
with an ICMJE-approved registry, such as
ClinicalTrials.gov. I confirm that any such study
reported in the manuscript has been registered and
the trial registration ID is provided (note: if posting a
prospective study registered retrospectively, please
provide a statement in the trial ID field explaining why
the study was not registered in advance).

Yes

I have followed all appropriate research reporting


guidelines and uploaded the relevant EQUATOR
Network research reporting checklist(s) and other
pertinent material as supplementary files, if applicable.

Yes

Copyright The copyright holder for this preprint is


the author/funder, who has granted
medRxiv a license to display the preprint
in perpetuity. All rights reserved. No
reuse allowed without permission.

 Back to top

 Previous Next 

Posted July 07, 2022.

 Download PDF  Email


 Print/Save Options  Share
 Author Declarations  Citation Tools
 Data/Code

Post Suka 0

COVID-19 SARS-CoV-2 preprints


from medRxiv and bioRxiv
Subject Area

Public and Global Health

Subject Areas

All Articles
Addiction Medicine

Allergy and Immunology

Anesthesia

Cardiovascular Medicine

Dentistry and Oral Medicine

Dermatology

Emergency Medicine

Endocrinology (including Diabetes Mellitus and


Metabolic Disease)

Epidemiology

Forensic Medicine

Gastroenterology

Genetic and Genomic Medicine

Geriatric Medicine

Health Economics

Health Informatics

Health Policy

Health Systems and Quality Improvement

Hematology

HIV/AIDS

Infectious Diseases (except HIV/AIDS)

Intensive Care and Critical Care Medicine

Medical Education

Medical Ethics

Nephrology

Neurology

Nursing

Nutrition

Obstetrics and Gynecology

Occupational and Environmental Health

Oncology

Ophthalmology

Orthopedics

Otolaryngology

Pain Medicine

Palliative Medicine

Pathology

Pediatrics

Pharmacology and Therapeutics

Primary Care Research

Psychiatry and Clinical Psychology

Public and Global Health

Radiology and Imaging

Rehabilitation Medicine and Physical Therapy

Respiratory Medicine

Rheumatology

Sexual and Reproductive Health

Sports Medicine

Surgery

Toxicology

Transplantation

Urology

You might also like